Filament CEO: Natural Psilocybin Is the Logical Option, So Why Is the Industry Stuck on Synthetic?

Filament Health Reports Q4 And Year End 2022 Financial Results And Operational Highlights

Inside the Vancouver lab where scientists (legally) grow magic mushrooms

Filament Health Announces FDA Approval Of Phase II Clinical Trial Studying Psilocybin For Methamphetamine Use Disorder